|
|
|
|
|
OPhir Nave and Moriah Sigron
Skin cancer treatment is a combination of BRAF and MEK kinase inhibitors administered as tablets, along with immunotherapy treatment (treatment into the vein) with a group of drugs that inhibit the activity of the immune barrier proteins PD-1 and PDL1. H...
ver más
|
|
|
|
|